Currently, the 750mcg teriparatide injection formulation is available in AU but this supply is conditional. Usually , it’s prescribed for patients with significant osteoporosis who have an lack to respond adequately to, or are unable tolerate, alternative therapies. The pricing can differ significantly depending on the supplier, coverage level ,